Terms: = Sarcomas AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Clinical Outcome
1 results:

---

1. Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma.
Martín-Broto J; Pousa AL; Brohl AS; Van Tine BA; Powers B; Stacchiotti S; Blay JY; Hu JS; Oakley GJ; Wang H; Szpurka AM; Levy DE; Mo G; Ceccarelli M; Jones RL
Mol Cancer Ther; 2021 Jan; 20(1):132-141. PubMed ID: 33177152
[TBL]

[Abstract]

[Full Text] [Related]  

---

of 1.